Revolution Medicines (RVMD) Assets Average (2020 - 2026)

Revolution Medicines has reported Assets Average for 7 years, with the latest figure at $2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 6.41% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (down 6.41% YoY), and the FY2025 full-year result was $2.5 billion, up 6.34% from the prior year.
• Assets Average for Q1 2026 stood at $2.3 billion, roughly flat from $2.3 billion in the prior quarter.
• The five-year high for Assets Average was $2.5 billion in Q1 2025, with the low at $657.8 million in Q2 2022.
• Average Assets Average over 5 years is $1.6 billion, with a median of $1.8 billion recorded in 2024.
• Year-over-year, Assets Average fell 17.03% in 2022 and soared 110.59% in 2024.
• Tracing RVMD's Assets Average over 5 years: stood at $818.9 million in 2022, then surged by 85.97% to $1.5 billion in 2023, then jumped by 41.87% to $2.2 billion in 2024, then grew by 6.6% to $2.3 billion in 2025, then grew by 0.04% to $2.3 billion in 2026.
• The last three Assets Average figures came in at $2.3 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.

Peer Comparison